7.57BMarket Cap-11.37P/E (TTM)
41.170High39.200Low567.66KVolume40.220Open40.670Pre Close22.83MTurnover0.34%Turnover RatioLossP/E (Static)185.91MShares62.40052wk High3.34P/B6.85BFloat Cap29.17052wk Low--Dividend TTM168.21MShs Float62.400Historical High--Div YieldTTM4.84%Amplitude14.080Historical Low40.223Avg Price1Lot Size
Revolution Medicines Stock Forum
Revolutionary KRAS Cancer Drug Achieves 61% Response Rate in Lung Cancer Patients - Key Trial Data Released
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$